Thomas Doyle - Jan 27, 2023 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
SVP, Finance & Accounting
Signature
Teresa Bair, Attorney-in-fact for Thomas Doyle
Stock symbol
KURA
Transactions as of
Jan 27, 2023
Transactions value $
-$21,502
Form type
4
Date filed
1/31/2023, 04:14 PM
Previous filing
Feb 9, 2022
Next filing
Feb 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale -$9.47K -682 -3.71% $13.89 17.7K Jan 27, 2023 Direct F1, F2
transaction KURA Common Stock Sale -$12K -866 -4.89% $13.89 16.8K Jan 27, 2023 Direct F3
holding KURA Common Stock 500 Jan 27, 2023 spouse's 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 1/26/22.
F2 Includes 1,806 shares acquired on May 17, 2022 and 1,583 shares acquired on November 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
F3 Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 2/7/22.